Belgium· BE-AMP-SAM233326-00
Fomepizole Serb 5 mg/ml
A fomepizole product containing fomepizole sulfate, registered in Belgium by SERB. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Fomepizole is registered in 14 of 19 countries.
Countries holding a registration under ATC V03AB34 (fomepizole), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Fomepizole · ATC V03AB34
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Fomepizole Sulfate
- Manufacturer
- SERB
- Country
- Belgium (BE)
- ATC code
- V03AB34
- ATC class
- Fomepizole
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2116937
- be_apb7736036
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for fomepizole.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fomepizole · interactions on record
4 records
- 4 severe
Most severe, free to view
- EthanolB05XX04severe
- EthanolV03AB16severe
- EthanolV03AZ01severe
- EthanolV07AB03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fomepizole in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFOMEPIZOLE SERB
- FinlandFomepizole SerbSERB S.A.
- IrelandFomepizole SERB 5 mg/mL, concentrate for solution for infusion.SERB S.A.
- NorwayFomepizole SerbSERB S.A.
- SwedenFomepizole SERB 5 mg/ml Koncentrat till infusionsvätska, lösningSERB S.A.
- GermanyFomepizole SerbSerb Sa
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Fomepizole Serb
- Germany · Fomepizole Serb
- Finland · Fomepizole Serb
- France · Fomepizole Serb
- Ireland · Fomepizole Serb
- Iceland · Fomepizole Serb
- Luxembourg · Fomepizole Serb
- Malta · Fomepizole Serb
- Netherlands · Fomepizole Serb
- Norway · Fomepizole Serb
- Sweden · Fomepizole Serb
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eda8fe16-7ac4-43b4-952e-5c4a5db723ce GET /v1/drugs/eda8fe16-7ac4-43b4-952e-5c4a5db723ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Fomepizole Serb 5 mg/ml",
"name_fr": "Fomepizole Serb 5 mg/ml",
"name_nl": "Fomepizole Serb 5 mg/ml",
"amp_code": "SAM233326-00",
"strengths": [
"8.0000",
"5.0000",
"138.0000"
],
"pack_count": 1,
"substances": [
"Fomepizole Sulfate",
"Fomepizole",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Fomepizole",
"authorisation_numbers": [
"BE233326"
]
}See everything about fomepizole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.